Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Change in Acquisitions & Divestments (2024)

Historic Change in Acquisitions & Divestments for Harvard Bioscience (HBIO) over the last 4 years, with Q2 2024 value amounting to $1.4 million.

  • Harvard Bioscience's Change in Acquisitions & Divestments changed N/A to $1.4 million in Q2 2024 from the same period last year, while for Mar 2025 it was $1.4 million, marking a year-over-year increase of 18767.68%. This contributed to the annual value of $1.9 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Harvard Bioscience reported Change in Acquisitions & Divestments of $1.4 million as of Q2 2024.
  • In the past 5 years, Harvard Bioscience's Change in Acquisitions & Divestments ranged from a high of $1.4 million in Q2 2024 and a low of $495000.0 during Q1 2024